Controlled dosing
Designed to deliver consistent, measured doses.
Innovative technology. Patient-focused treatments.
Acrux has developed proprietary transdermal drug delivery technologies designed to deliver medicines through the skin in a controlled, convenient and patient-friendly way.

Our Metered Dose Transdermal System (MDTS) combines a metered-dose spray applicator with specialised formulation technology to facilitate the delivery of active pharmaceutical ingredients through the skin.
Acrux is leveraging this technology to advance Female Testosterone MDTS, an investigational treatment for postmenopausal women with hypoactive sexual desire disorder (HSDD).

Designed to deliver consistent, measured doses.
A spray-based alternative to patches and other delivery methods.
Specialised formulations designed to facilitate drug absorption through the skin.
Supported by Acrux's experience developing commercially approved hormone therapies.